NCT02852317 Urinary Markers of Detrusor Overactivity in Spina Bifida Patients Status COMPLETED Phase N/A
NCT02835846 Investigation of the Effect of the Female Urinary Microbiome on Incontinence Status COMPLETED Phase PHASE4
NCT02821312 A Study to Evaluate Safety, Tolerability and Pharmacokinetics of DA-8010 in Healthy Subjects Status UNKNOWN Phase PHASE1
NCT02805452 Solifenacin Succinate for Treatment of Urinary Toxicity Occurring During Radiotherapy of Prostatic Cancer Status TERMINATED Phase PHASE3
NCT02790307 Transcutaneous Tibial Nerve Stimulation of Patients With Overactive Bladder (OAB) Syndrome Status COMPLETED Phase PHASE2
NCT02786407 A Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A in Patients With Overactive Bladder (OAB) Status UNKNOWN Phase PHASE3
NCT02757768 A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH) Status COMPLETED Phase PHASE4
NCT02735499 Instillation of Botox in the Bladder in Women With Overactive Bladder (OAB) Status COMPLETED Phase PHASE2
NCT02715024 Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms Status COMPLETED Phase PHASE4
NCT02674269 Safety and Efficacy Study of Intravesical Instillations of BotuGelTM, Slow Release RTGel Based Botox® Formulations, in Idiopathic OAB Patients With Urinary Incontinence ("INTIMO2") Status WITHDRAWN Phase PHASE1/PHASE2
NCT02667470 Reproducibility Study of OABSS and Its Response to Treatment Status COMPLETED Phase PHASE4
NCT02660359 Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 2 Status TERMINATED Phase PHASE3
NCT02660138 Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1 Status TERMINATED Phase PHASE3
NCT02657057 Effects of Transcutaneous and Percutaneous PTNS on Idiopathic OAB Status COMPLETED Phase NA
NCT02656173 A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH) Status COMPLETED Phase PHASE4
NCT02622555 Cardiovascular Morbidity During Treatment of Overactive Bladder With B3 Agonists Status COMPLETED Phase N/A
NCT02620410 Treatment of REfractory Overactive BLadder With the AXonics Sacral Neuromodulation System (RELAX-OAB) Status COMPLETED Phase NA